| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.06 |